ANVISA halts some China-made IVD import approvals, disrupting Brazil-bound diagnostics shipments. Learn what IEC 62304:2023 compliance gaps mean for customs, distributors, and supply chains.

FDA updates IVD software rules with new AI validation package requirements for U.S.-bound diagnostic devices. Learn how this change may affect registration timelines, compliance workflows, and market entry planning.

FDA draft guidance on AI diagnostic data origin raises new U.S. market access demands. Learn how training data provenance, compliance documentation, and export timelines may impact AI diagnostic software.

CMEF Shanghai 2026 ends with buyer intent up 37%, signaling rising demand for sterilization equipment, digital dental systems, and diagnostic instruments. Explore the market implications now.

China-Malaysia Device Fast-Track opens in 30 days, helping medical device exporters and importers cut duplicate trials, speed compliance, and unlock faster Southeast Asia market access.

Hong Kong opens a clinical data route to CE and GCC, helping Advanced Imaging and Clinical Diagnostic Instrument companies turn local GCP data into smarter multi-market registration plans.

Langfang 2026 matchmaking opens lab diagnostics orders, signaling bulk demand for biochemistry analyzers, centrifuges, and POCT platforms. See what buyers now require on compliance and local service.

China medical device exports rose 9.64% in Jan–Apr 2026, led by ultrasound and diagnostic instruments. Discover what this means for exporters, buyers, and supply chains.

Medical device trade report spotlights 12 buyer markets, revealing importer contacts, procurement preferences, and market-entry risks to help exporters, manufacturers, and distributors sharpen global sales strategy.

China approves 318 domestic medical devices, highlighting proton therapy, imaging and diagnostic advances that may open new export and cooperation opportunities.